EdgarLookup
SC 13G/A

AMENDMENT NO. 1 TO SCHEDULE 13G

Company
NeuroSense Therapeutics Ltd.
Filed
March 15, 2023
Accession Number
0001213900-23-020281
View Document ↗ View on SEC.gov ↗